The collaboration is anchored in Syngene’s SynVent platform and Connector model to accelerate promising academic researchSyngene International, a global contract research, development, and manufacturing organization (CRDMO), today announced a strategic collaboration with Johns Hopkins University, MD, U.S., to advance early-stage drug discovery programs and platform